Hongyan Zou, MD, PhD Email Hongyan Zou
-
- Positions
- ASSOCIATE PROFESSOR | Neurosurgery
- ASSOCIATE PROFESSOR | Neuroscience
-
- Specialties
- Spine Surgery
- Neurosurgery
-
- Languages
- Chinese (Cantonese)
- Chinese (Mandarin)
- English
-
- Hospital Affiliation
- The Mount Sinai Hospital
-
- Phone
- Mount Sinai Doctors Faculty Practice 212-241-8628212-241-8628
- Mount Sinai Doctors Specialty Practice 212-731-3610212-731-3610
- Advantage Medical Health Care 212-241-8628212-241-8628
Dr. Hongyan Zou focuses her clinical practice on minimally-invasive and complex spine surgery, brain and spine tumors, and general neurosurgery.
Read Dr. Zou's profile in Chinese
Dr. Zou's research laboratory studies the molecular mechanisms of axonal growth and neurogenesis. Her research supports the development of molecular treatments for neuronal and axonal regeneration.
Zou lab website
Certification
Neurology
Clinical Focus
- Acoustic Neuroma
- Acoustic Neuroma Removal
- Biopsy
- Bone Cancer
- Brain Tumor And Brain Cancer
- Brain, Spine Tumors
- Carpal Tunnel Release
- Carpal Tunnel Syndrome
- Cauda Equina Syndrome
- Cervical Myelopathy
- Chiari Malformation
- Chronic Neck Pain
- Craniotomy
- Degenerative Disc Disease
- Glioblastoma Multiforme
- Herniated Disk
- Kyphosis
- Laminectomy
- Low Back Pain
- Meningioma
- Minimally Invasive Spine Surgery
- Neck Fracture
- Pituitary Adenoma
- Quadriplegia And Paraplegia
- Sciatica
- Spinal Cord Injury
- Spinal Cord Tumors
- Spinal Fusion
- Spondylolisthesis
- Trigeminal Neuralgia
- Vertebroplasty And Kyphoplasty
Research Topics
Axon Guidance, Axonal Growth and Degeneration, Brain, Cancer Genetics, Developmental Neurobiology, Epigenetics, Neurobiology, Regeneration, Spinal Cord, Stem Cells, Transcription Factors, Tumorigenesis
Multi-Disciplinary Training Areas
Genetics and Genomic Sciences [GGS], Neuroscience [NEU]
Education
MD, Stanford University School of Medicine
PhD, Cornell University and Memorial Sloan-Kettering Institute
Internship, General Surgery
Stanford University Hospital
Residency, Neurosurgery
Stanford University Hospital
Languages
Chinese (Cantonese), Chinese (Mandarin), English
2013
NIH R21
National Institutes of Health
Award for the research of brain tumor biology
2013
National Innovative Research Award Grant
American Heart Association
2011
NIH R01
National Institutes of Health
Award for the research of molecular mechanisms to promote axon regeneration
2011
Craig H. Neilsen Foundation Award
2010
Young Clinician Investigator Award for Young Faculty
NREF (Neurosurgery Research and Education Foundation) of the AANS (American Association of Neurological Surgeons)
2010
Transcriptional regulation of the intrinsic axon growth capacity during development
Whitehall Foundation
Grant supporting research for basic neuroscience
2010
Dr. Harold and Golden Lamport Research Award
The award is given to tenure-track assistant professors who show exceptional potential for making significant contributions.
2007
Congress of Neurological Surgeons Resident Award
2006
NRSA/NINDS Postdoctoral Fellowship
2000
Baxter Foundation Grant
1996
Frank Lappin Horsfall Jr. Fellowship
1996
Julian R. Rachele Prize
Specific Research Interests
- Molecular mechanisms of axon growth
- Transcription factors regulating axonal regeneration
- Neural stem cell proliferation, differentiation, and implication in CNS tumorigenesis
Our lab is interested in understanding how neurons are born, how they extend axons, and how they regenerate or fail to regenerate after injury. Brain and spinal cord injuries account for billions of dollars each year in medical costs. Understanding classic and identifying novel signaling pathways that promote neurogenesis and axonogenesis will provide new molecular targets towards effective CNS regeneration. Similar mechanisms that regulate the neural stem cell niche also regulate brain tumor stem cells. Developing strategies to shrink the tumor stem cell pool by inhibiting proliferation, inducing apoptosis or promoting differentiation will have great impact on treating primary brain tumors.
Zou lab website
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Zou did not report having any of the following types of financial relationships with industry during 2017 and/or 2018: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website.
Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.